PD-1/PD-L1 immune checkpoint inhibitors in Hodgkin lymphoma: A meta- and network meta-analysis
Translational Oncology · 2026-09 · 71 · 102873
DOI: 10.1016/j.tranon.2026.102873 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Oncology, 2026-09. Verfasst von Tingxi Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, 610000, China; Med-X Center for Informatics, Sichuan Univers…. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sichuan University, Sichuan University West China Hospital.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, 610000, China; Med-X Center for Informatics, Sichuan University, Chengdu, 610000, China.
- Mental health center, West China Second University Hospital, Sichuan University, Chengdu, 610000, China.
- Pittsburgh Institute, Sichuan University, Chengdu, 610000, China.
- West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, 610000, China; Med-X Center for Informatics, Sichuan University, Chengdu, 610000, China. Electronic address: yangxiaoyan@scu.edu.c…
Förderung
- Sichuan University
- Sichuan University West China Hospital
Zitieren
APA
Zhu, T., Liu, Z., Sun, H., Lin, T., Lu, Z., & Yang, X. (2026). PD-1/PD-L1 immune checkpoint inhibitors in Hodgkin lymphoma: A meta- and network meta-analysis. Translational Oncology, 71, 102873. https://doi.org/10.1016/j.tranon.2026.102873
Vancouver
Zhu T, Liu Z, Sun H, Lin T, Lu Z, Yang X. PD-1/PD-L1 immune checkpoint inhibitors in Hodgkin lymphoma: A meta- and network meta-analysis. Translational Oncology. 2026;71:102873. doi:10.1016/j.tranon.2026.102873
BibTeX
@article{Zhu2026,
author = {Zhu, Tingxi and Liu, Zhongyu and Sun, Huan and Lin, Tianchi and Lu, Zhe and Yang, Xiaoyan},
title = {PD-1/PD-L1 immune checkpoint inhibitors in Hodgkin lymphoma: A meta- and network meta-analysis},
journal = {Translational Oncology},
year = {2026},
volume = {71},
pages = {102873},
doi = {10.1016/j.tranon.2026.102873}
}
EUVIMED